Uncategorized

Revolution Medicines leads latest wave of stock offerings, totaling $1.5B

Published

on

Another stock offering blitz is adding more fuel to biotech investors’ belief in the sector.

Revolution Medicines anchored Monday’s offering surge, while Spyre Therapeutics and Allogene Therapeutics also joined in. The trio is planning to …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version